Vitamin C

Producer:Henan Lvyuan Pharmaceutical Co., Ltd. is a modern high-tech pharmaceutical joint-stock enterprise jointly invested and constructed by Liuzhuang village and several domestic companies. It covers an area of 266800 square meters, a planned construction area of 110000 square meters and a total investment of more than 1 billion yuan

Lvyuan pharmaceutical attaches great importance to the introduction, training and development of talents, and has established a perfect quality assurance system. The company has more than 1000 employees, of which more than 30% are professional technicians, who are fully responsible for the R & D and quality supervision of the company's products.

Staff size:100-199 people

Registered capital:RMB 650 million

Producer:Shandong Luwei Pharmaceutical Co., Ltd. was established in 1994, covering an area of more than 200 mu. It has VC plant, sorbitol plant, self owned power plant and sewage treatment plant. It is one of the five major vitamin C production enterprises in China. Quantity system certification, ISO22000 food safety management system certification, ISO14000 environmental management system certification, ISO18000 occupational health and safety system certification,   Three level safety standardization certification, IP non GMO identity maintenance product certification, fami-qs European feed additive and premix feed quality system certification, kosher   Halal International Religious clean food certification.

Staff size:1000-1999 people

Registered capital:USD 10 million

Producer:Established in 1990, DSM Jiangshan Pharmaceutical (Jiangsu) Co., Ltd. (formerly Jiangsu Jiangshan Pharmaceutical Co., Ltd.) is a major vitamin C manufacturer in the world. The product quality complies with international standards such as British Pharmacopoeia, European Pharmacopoeia, American Pharmacopoeia, Japanese Pharmacopoeia, Chinese Pharmacopoeia and FCC, and is produced and operated in accordance with the requirements of GMP, ISO9001, ISO14001, GB / T28001, fssc22000, CEP, jdmf, IP, fami-qs, halal, kosher, SEDEX and other quality systems and management systems.

Staff size:1000-1999 persons

Registered capital:RMB 323 million 121 thousand and 593

Producer:Hulun Buir Northern Pharmaceutical Co., Ltd. is subordinate to Shenyang Tonglian Group Co., Ltd. and its production varieties include vitamin C, gulonic acid, 6-APA, penicillin industrial potassium salt, rifamycin, erythromycin thiocyanate, colimycin, etc.

Staff size:100-199 people

Registered capital:RMB 2 billion 432 million 638 thousand 

Producer:Northeast Pharmaceutical Group Co., Ltd. is a listed company of Liaoning Fangda Group Industry Co., Ltd. The company, formerly known as Northeast Pharmaceutical General Factory, was founded in 1946.

The preparation production base covers an area of 180000 square meters, with more than 30 production lines and an annual production capacity of 10 billion tablets (sticks, pills, granules, pieces and bottles). The API production base covers an area of 910000 square meters. It is a national intelligent manufacturing demonstration factory for bulk APIs and pharmaceutical intermediates.

The product quality complies with the latest quality standards such as GMP, EP, USP, JP, BP and CP. Many products have passed international high-end certification such as EDQM, FDA, Japan's Ministry of health and welfare, BRC, halal, kosher, etc. The leading products have passed the registration and quality audit in the United States, Europe, Japan, Brazil, Russia, Poland and other countries and regions.

Staff size:About 8000 people

Registered capital:RMB 1 billion 348 million

Producer:Hebei Welcome Pharmaceutical Co., Ltd. was jointly built by North China Pharmaceutical Co., Ltd. and Hong Kong Sanwei International Co., Ltd. in 1993. The production capacity, product quality and various economic and technical indicators of vitamin C API have reached the domestic leading level, and have successively passed ISO9001 quality system certification, ISO14001 environmental system certification and national GMP certification.

 Staff size:About 50 persons

Registered capital:RMB 171 million 708 thousand and 450

Producer:Founded in 1994, CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.

of Shijiazhuang Pharmaceutical Group covers a total area of 226000 square meters. The annual production capacity of vitamin C and its series products reaches 50000 tons. The company has also passed a series of certification, including China GMP, Japan GMP, ISO9001, BRC, HACCP and other management system certification.

Staff size:1000-1999 people

Registered capital:USD 27 million 345 thousand and 500

Producer:Beijing Shuanglu Pharmaceutical Co., Ltd. is the first high-tech enterprise in the capital to land on the SME Board of Shenzhen Stock Exchange. Since its establishment in 1994, relying on its technical advantages and continuous innovation, the company has researched, developed and put on the market more than 70 varieties of three national class I new drugs with independent intellectual property rights. The company has eight production bases, with a total area of 150000 square meters, The production capacity covers the high-tech fields involved in new pharmaceutical projects such as biological fermentation, biochemistry, traditional Chinese medicine extraction, chemical raw materials and antibodies, as well as oral solid preparations and production lines dedicated to water injection, powder injection, external medicine and anti-tumor in strict accordance with international GMP standards.
Staff size:About 800 persons

Registered capital:RMB 1 billion 27 million

Producer:Shanxi Pude pharmaceutical Co., Ltd., founded on September 13, 1995, is a wholly-owned subsidiary of Harbin Yuheng Pharmaceutical Co., Ltd.

The company now has 35 national new drugs and 31 invention patents. It has 22 production lines for freeze-dried powder injection, small volume injection, powder injection, oral preparation, chemical synthesis, traditional Chinese medicine extraction, biochemical pretreatment and 7 production workshops. The existing production line can produce 60 million powder injections / year; 80 million small volume injections / year; 100 million lyophilized powder injections / year; Sterile API 60 t / year.

Staff size:About 600 people

Registered capital:RMB 138.8 million

Producer:Chongqing Juqi nomey Pharmaceutical Co., Ltd. was established in 2006. The raw materials, traditional Chinese medicine extraction, tablets, capsules, granules and ointments have passed the 2010 GMP certification and obtained the GMP certificate. The designed production capacity is: 200 million tablets / year, 120 million capsules / year, 30 million bags / year of granules, 4 million bottles / year of decoctions, 40 million pieces / year of small volume injections, and 20 tons / year of synthetic raw materials.

Staff size:50-99 persons

Registered capital:RMB 30 million

Producer:Shanghai SPH New Asia Pharmaceutical Co., Ltd. (Shanghai New Asia Pharmaceutical Co., Ltd.) is a subsidiary of Shanghai Pharmaceutical Group Co., Ltd. The company's flagship products, such as ceftriaxone, cefotaxime, cefoperazone, cefotiam and cefazolin, enjoy a good reputation in the domestic market.

Staff size:900-999 people

Registered capital:RMB 1 billion 52 million 429 thousand and 132

Producer:CSPC Ouyi Pharmaceutical Co., Ltd. is a listed enterprise under CSPC Pharmaceutical Group Co., Ltd.

The company has four pharmaceutical preparation production buildings designed according to GMP standards and four API production lines with international advanced level. The product dosage forms include small volume injection, powder injection, freeze-dried powder injection, tablet, hard capsule, soft capsule, granule, dry suspension, etc. The annual production capacity is: 9 billion tablets, 400 million hard capsules, 400 million soft capsules, 600 million bags of granules, 600 million small volume injections, 300 million powder injections and 200 million bags of dry suspensions. The product quality meets BP, USP, JP and EP standards respectively according to different requirements of customers. The company has passed the national GMP quality certification, "zero defect item" has passed the FDA certification of the United States, has also passed the MCC quality certification of South Africa, and many varieties have obtained the EU CEP certificate.

Staff size:4000-4999 people

Registered capital:RMB 300 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +8618402846978